2024
The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review
Shah A, Ding Y, Walji D, Rabinovich G, Pelletier M, El-Diasty M. The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review. Biomarkers 2024, 29: 485-493. PMID: 39422445, DOI: 10.1080/1354750x.2024.2415073.Peer-Reviewed Original ResearchConceptsAssociated with acute kidney injuryPostoperative atrial fibrillationGal-3 levelsLeft ventricular reverse remodelingCardiac surgeryAdverse outcomesGal-3Clinical risk prediction scorePreoperative plasma levelsVentricular reverse remodelingEuroSCORE II modelPlasma Gal-3 levelsPostoperative adverse outcomesAcute kidney injuryGalectin-3Group of patientsPredicting adverse outcomesRisk prediction scorePostoperative morbidityReverse remodelingPostoperative mortalityElectronic database searchPrognostic utilityAdult patientsKidney injury
2018
Mechanical Versus Bioprosthetic Aortic Valve Replacement in Patients Aged 50Â Years and Younger
Hirji S, Kolkailah A, Ramirez-Del Val F, Lee J, McGurk S, Pelletier M, Singh S, Mallidi H, Aranki S, Shekar P, Kaneko T. Mechanical Versus Bioprosthetic Aortic Valve Replacement in Patients Aged 50 Years and Younger. The Annals Of Thoracic Surgery 2018, 106: 1113-1120. PMID: 29966596, DOI: 10.1016/j.athoracsur.2018.05.073.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAortic Valve StenosisBioprosthesisCohort StudiesDatabases, FactualFemaleHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHospital MortalityHumansKaplan-Meier EstimateMaleMiddle AgedPostoperative ComplicationsPostoperative HemorrhagePrognosisPropensity ScoreProportional Hazards ModelsProsthesis DesignReoperationRetrospective StudiesRisk AssessmentSurvival AnalysisConceptsMechanical aortic valve replacementBioprosthetic AVRAortic valve replacementLong-term survivalOperative mortalityValve replacementRedo-AVRConcomitant coronary artery bypass graftingLong-term survival differenceEnd pointsIncreased risk of reoperationBioprosthetic aortic valve replacementCoronary artery bypass graftingMitral valve proceduresMedian observation timeSecondary end pointsMechanical aortic valve replacement patientsPrimary end pointRisk of reoperationArtery bypass graftingStudy evaluated outcomesValve proceduresBleeding incidenceYounger patientsSurvival differences
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply